P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

Adalimumab and secukinumab are the only FDA-approved biologic drugs to treat hidradenitis suppurativa, limiting options for ...

Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profileMean change in UAS7 ...

A new method of treating common inflammatory skin conditions like eczema could be on the horizon, according to a recent study. American researchers found that a compound named SYM2081 inhibited ...

EVO-301 is under clinical development by Evommune and currently in Phase I for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease). According to GlobalData, Phase I drugs for Systemic-Onset ...

Urticaria affects 10% to 25% of the population at some point in their life (Henderson, Fleischer, & Feldman, 2000). It is characterized by short-lived swellings of the skin, mouth, and genitalia ...

Irene Jimenez Padilla used to suffer persistent traumatic flashbacks from her time as a nurse during the Covid-19 pandemic. Then a cult computer puzzle game changed everything. Ms Padilla was ...

European Foulbrood (EFB) is a severe bacterial disease affecting honeybees, primarily caused by the Gram-positive bacterium Melissococcus plutonius. Although the presence of M. plutonius is associated ...

LOS ANGELES—Noah Hudnut’s family had already spent $150,000 on his psychiatric care when he was hauled in handcuffs by police to the emergency room of UCLA medical center. On top of the ...

Introduction: This systematic review and meta-analysis aimed to systematically assess the effect size of conservative methods based on exercise for respondents with idiopathic scoliosis. Methods: This ...

Background: Chronic idiopathic urticaria is a distressing condition that severely affects patients' quality of life. The overall costs associated with this disease, both for the healthcare payer ...